Tapinarof for the Treatment of Atopic Dermatitis in Children

This study is currently closed to enrollment.

AGE: 2-17 years old
SEX AT BIRTH: All

TYPE: Investigational Treatment Study
CONDITION: Atopic Dermatitis

HEALTHY PARTICIPANTS: No
LOCATION: University Hospitals Medical Centers

Study Purpose

The purpose of this investigational study is to assess the safety and efficacy (how well it works) of tapinarof cream, 1% compared to a vehicle cream when applied once daily for 8 weeks for the potential topical (on the surface of your skin) treatment of atopic dermatitis.

STUDY20220598
NCT05014568